Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Huamao Pharmaceutical is a comprehensive pharmaceutical enterprise based in Dunhua, Jilin Province, China. The company specializes in the research, development, and large-scale production of both traditional Chinese medicines (TCM) and chemical generic drugs. Its manufacturing facilities are GMP-certified for multiple dosage forms, including tablets, capsules, and granules, with a strong emphasis on TCM extraction processes utilizing resources from the Changbai Mountain region. The product portfolio covers a wide range of therapeutic areas such as cardiovascular health, respiratory infections, and metabolic disorders. Jilin Huamao primarily serves the domestic Chinese market, positioning itself as a provider of essential and affordable medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Huamao Pharmaceutical.